Alafi Capital updates CalciMedica (NASDAQ: CALC) stake after multimillion-warrant grant
Rhea-AI Filing Summary
CalciMedica, Inc. (CALC) received an updated Schedule 13D from Alafi Capital Company LLC and Christopher D. Alafi reporting their beneficial ownership of 7,220,101 shares of common stock and related warrants, representing 19.9% of the class based on 34,141,460 shares outstanding as of August 20, 2026.
The position includes 5,112,345 common shares plus multiple warrant series. On August 19, 2026, after Stockholder Approval, the reporting persons received 3,529,192 Series A Warrants and 3,529,192 Series B Warrants. Due to a 19.99% beneficial ownership limitation, 2,605,965 Series A Warrants and 2,605,965 Series B Warrants are not currently exercisable. The filing states the amendment’s purpose is solely to reflect this warrant issuance, with no stated change in transaction purpose.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 7,220,101 shares
Ownership percentage: 19.9%
Shares outstanding: 34,141,460 shares
+5 more
8 metrics
Beneficial ownership
7,220,101 shares
Shares of CalciMedica common stock and warrants beneficially owned by each reporting person
Ownership percentage
19.9%
Percent of CalciMedica common stock class represented by the 7,220,101 shares
Shares outstanding
34,141,460 shares
CalciMedica common stock outstanding as of August 20, 2026 used in ownership calculation
Common shares held
5,112,345 shares
Common stock held directly by the reporting persons
Warrants at $7.15
130,651 warrants
Warrants to purchase common stock at an exercise price of $7.15
Warrants at $0.8033
923,227 warrants
Warrants to purchase common stock at an exercise price of $0.8033
Warrants at $1.00
923,227 warrants
Warrants to purchase common stock at an exercise price of $1.00
New Series A and B Warrants
3,529,192 Series A and 3,529,192 Series B Warrants
Warrants received on August 19, 2026 following Stockholder Approval
Key Terms
beneficial ownership limitation, Series A Warrants, Series B Warrants, dispositive power, +1 more
5 terms
beneficial ownership limitation regulatory
"not currently exercisable due to the 19.99% beneficial ownership limitation included in such warrants"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Series A Warrants financial
"the Reporting Persons received 3,529,192 Series A Warrants and 3,529,192 Series B Warrants"
Series A warrants are financial tools that give the holder the right to buy shares of a company at a specific price within a certain period. They are often issued alongside investments to provide additional potential profit if the company's value increases. For investors, they can offer a chance to benefit from future growth without committing immediate capital to buying shares.
Series B Warrants financial
"the Reporting Persons received 3,529,192 Series A Warrants and 3,529,192 Series B Warrants"
Series B warrants are contracts issued alongside a company's Series B financing that give the holder the right to buy a set number of shares at a fixed price within a specified time. For investors, they matter because they can provide leveraged upside if the company grows, or they can dilute existing shareholders when exercised—like a coupon promising a future share at a known price that can add value or change ownership stakes.
dispositive power regulatory
"Number of Shares Beneficially Owned by Each Reporting Person With: Sole Dispositive Power"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
pecuniary interest regulatory
"Except to the extent of his or its pecuniary interest therein, each Reporting Person disclaims"
FAQ
What ownership stake in CALC is reported in this Schedule 13D/A?
The reporting persons disclose beneficial ownership of 7,220,101 shares of CalciMedica common stock and warrants, representing 19.9% of the class based on 34,141,460 shares outstanding as of August 20, 2026.
Who are the reporting persons in this CALC Schedule 13D/A amendment?
The reporting persons are Alafi Capital Company LLC and Christopher D. Alafi. Alafi Capital is organized in California, and Christopher D. Alafi is a United States citizen and managing member of Alafi Capital Company LLC.
What triggered this Amendment No. 1 to the CALC Schedule 13D?
The amendment was triggered solely to reflect that, on August 19, 2026, the reporting persons received 3,529,192 Series A Warrants and 3,529,192 Series B Warrants, following the receipt of Stockholder Approval.
How is the 7,220,101 CALC beneficial ownership position composed?
It includes 5,112,345 common shares, plus warrants: 130,651 at an exercise price of $7.15, 923,227 at $0.8033, and 923,227 at $1.00, all held by the reporting persons.
Which CALC warrants are not currently exercisable under the 13D/A?
The filing states that 2,605,965 Series A Warrants and 2,605,965 Series B Warrants are not currently exercisable because of a 19.99% beneficial ownership limitation included in those warrants.
AI-generated analysis. How Rhea-AI works. Not financial advice.
